๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP ยท Real-Time Price ยท USD
68.55
-0.58 (-0.84%)
At close: Nov 20, 2026, 4:00 PM EST
68.90
+0.35 (0.51%)
After-hours: Nov 20, 2026, 7:39 PM EST

ANI Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,041883.37614.38486.82316.39216.14
Revenue Growth
25.94%43.78%26.20%53.87%46.38%3.67%
Gross Profit
635.8542.06377.77305.3177.6115.53
Operating Income
152.6183.3333.9249.53-25.73-28.17
Net Income
108.5370.22-20.1515.48-49.52-42.79
Earnings Per Share
5.003.32-1.040.85-3.05-3.40
EPS Growth
198.73%-----

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Generics and Other
421.8399.43320.03289.31235.24
Rare Disease and Brands
619.55483.93294.34197.581.15
Total
1,041883.37614.38486.82316.39

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
436.97294.72151.17221.1248.23100.3
Total Debt
617.36628.28624.09285.67287.9287.37
Net Cash (Debt)
-180.39-333.57-472.92-64.55-239.67-187.07
Net Cash Growth
------
Net Cash Per Share
-8.30-15.71-24.48-3.55-14.74-14.85

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
229.2185.2364.02118.96-31.23.32
Capital Expenditures
-23.87-13.84-16.24-8.87-8.88-2.56
Free Cash Flow
205.32171.3947.78110.09-40.080.77
Free Cash Flow Growth
31.84%258.70%-56.60%---91.62%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.06%61.36%61.49%62.71%56.13%53.45%
Operating Margin
14.66%9.43%5.52%10.17%-8.13%-13.03%
Pretax Margin
15.16%10.84%-3.62%4.08%-19.81%-25.94%
Profit Margin
10.42%7.95%-3.28%3.18%-15.65%-19.80%
FCF Margin
19.72%19.40%7.78%22.61%-12.67%0.35%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.7023.50-68.00--
Forward PE
7.2610.0310.7214.0414.7912.86
P/FCF Ratio
7.079.6322.599.56-1008.43
PS Ratio
1.391.871.762.162.073.57